Wolfgang Scholz completed his medical education at the Universities of Mainz and Frankfurt. After that he specialized in ion transport in the kidney under acidic conditions at the University of Mainz. For 16 years he conducted cardiovascular research at former Hoechst AG, heading the NHE Research Team. Thereafter, he became the head of cardiovascular research at Merck KGaA Darmstadt and is now heading the drug repositioning activities at Merck Serono. Wolfgang now provides its know-how into NHE biology and contributes with his cardiovascular biomedical expertise to Esperare.
Wolfgang Scholz MD
As a private non-for-profit organisation, we strive to uncover the potential of existing molecules to address severe therapeutic unmet needs in rare diseases, thus giving better chances to existing drugs to reach these underserved patients.